Allevion Therapeutics is developing a smart wrist-wearable device (Allevx) to reduce hand and leg tremor, specifically essential tremor (ET). Allevx is considered to be the next-generation neuromodulation device that delivers an individualized noninvasive, multi-modal energy therapy to alter the activity of nerves responsible for tremors. This breakthrough energy system has the potential to address essential tremor and other movement-related disorders, such as Parkinson's disease and dystonia.
Date | Amount | Type | Investors | Valuation |
---|---|---|---|---|
09/23/20 | undisclosed |
Adventus Ventures | undisclosed |